Improved HPV vaccine uptake could prevent 200 cervical cancer cases every year
Around 200 cases of cervical cancer and 90 deaths from the disease could be prevented each year if uptake of the HPV (human papillomavirus) vaccine was increased in every region to just ten per cent more than the current national average, according to research1 presented at the Public Health England conference in Warwick. (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 16, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Drug delivery Industry News cervical cancer hpv vaccination Latest News uptake variation Source Type: news
Hundreds of girls taken to hospital after mass fainting spell linked to cervical cancer vaccine hits Colombia
More than 200 girls in El Carmen de Bolivar, on Columbia's coast, have mysteriously come down with symptoms, from fainting to numb hands, after all being injected with Gardasil (stock image). (Source: the Mail online | Health)
Source: the Mail online | Health - September 15, 2014 Category: Consumer Health News Source Type: news
ANH-Intl News Alerts: Week 36, 2014
Ashya King, Novartis cover up, Ebola vaccine, diabetics go low carbs, walking slashes cancer risk, hospital food, Monarch butterflies, GM and Gardasil (Source: Alliance for Natural Health)
Source: Alliance for Natural Health - September 2, 2014 Category: Complementary Medicine Authors: Sophie Tags: Ashya King cancer carbs diabetics Eatwell plate Ebola vaccine europe gardasil Germany GM heart disease hospital food international Japan leukemia Macmillan Monarch butterflies my plate Neon Roberts NHS NIH Novarti Source Type: news
The HPV vaccine: beating cervical cancer – questions and answers
The FAQ addresses questions about the human papillomavirus vaccine to protect girls against cervical cancer. (Source: NHS Networks)
Source: NHS Networks - August 21, 2014 Category: UK Health Authors: Maria Axford Source Type: news
ANH-Intl News Alerts: Week 30, 2014
GM, statins, evidence based medicine, modified protein, fracking, TTIP, Nurses Against Mandatory Vaccines, Monsanto, and Gardasil/Pandemrix paper retraction (Source: Alliance for Natural Health)
Source: Alliance for Natural Health - August 5, 2014 Category: Complementary Medicine Authors: Sophie Tags: ban brazil BT corn caterpillar Cholesterol Treatment Trialists climate change corn leafworm CTT Dow AgroSciences EBM EFSA EIA Engineering and Physical Sciences Research Council Environmental Impact Assessment EPSRC europe E Source Type: news
Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine
(Landes Bioscience) A long-term follow-up study shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papillomavirus vaccine Cervarix. Women vaccinated with the vaccine were followed for more than nine years, and vaccine efficacy against incident infection was 100 percent. This is the longest follow-up report for a licensed human papillomavirus vaccine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 31, 2014 Category: Cancer & Oncology Source Type: news
The Gardasil HPV Vaccine Doesn't Increase Blood Clot Risk
A very large study of the national health records of Denmark shows that quadrivalent HPV does not increase the risk of blood clots in the veins of girls and women, an earlier reported potential side effect of the vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 8, 2014 Category: Pharmaceuticals Authors: David Kroll Source Type: news
Study Shows No Link Between Gardasil And Blood Clots
One worry that has been raised about Merck's Gardasil vaccine, for the human papilloma virus that causes cervical cancer, is that it might be causing an increased risk of blood clots, which can be deadly. But it's difficult to know for sure whether a clot was caused by the vaccine, in part because they can occur in young woman without cause and in part because oral contraceptives raise the risk of clots, also known as venous thromboembolism or VTE. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 8, 2014 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news
Moral beliefs a barrier to HPV vaccine, researchers find
The biggest barrier to receiving a human papillomavirus vaccine was moral or religious beliefs, a survey of first-year students has indicated. The HPV vaccines are commonly recommended for children ages 11-12 to protect against cervical cancers in women, and genital warts and other cancers in men. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 7, 2014 Category: Science Source Type: news
GVSU researchers find moral beliefs barrier to HPV vaccine
(Grand Valley State University) A survey of first-year Grand Valley State University students showed the biggest barrier to receiving a Human Papillomavirus vaccine was moral or religious beliefs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2014 Category: Cancer & Oncology Source Type: news
Gardasil® HPV vaccine approved for the prevention of anal cancer
Sanofi Pasteur MSD announced today that the European Commission has granted marketing authorisation for the use of Gardasil® (human papillomavirus vaccine [types 6, 11, 16, 18] [recombinant, adsorbed]) for the prevention of anal precancerous lesions and anal cancers causally related to certain oncogenic human papillomavirus types in both males and females. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 19, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Oncology anal cancer gardasil hpv human papillomavirus Latest News Sanofi Pasteur MSD Source Type: news
This Week: Shakespeare on Richard III, Obesity Rates Up
(MedPage Today) -- Richard III's physical impairments, human papillomavirus vaccine barriers, and rising obesity rates topped the news in medicine this week. (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 30, 2014 Category: Endocrinology Source Type: news
